Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib with Carboplatin and Paclitaxel in BRCA-Mutated Advanced Breast Cancer
NCT02163694Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Apr 2014
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 37
01
Overview
A Phase 3 trial of veliparib in breast cancer, sponsored by AbbVie Inc.. Started Apr 2014; status: completed.
02
Drugs
veliparib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02163694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02163694.